PROJECTS
- 2017-2018
- “Investigation of drug resistance mechanisms for a new generation antiandrogen prostate cancer drug Enzalutamide using advanced molecular dynamics simulation techniques“
- Sefer Baday, Behzad Aslani Avilaq, Burak Islek
- funded by TUBITAK Career Development Program (3501)
- 2016-2018
- “User Friendly Analysis Platform for DNA Sequencing“
- Burak Islek, Ozkan Ozdemir, Aycan Adal)
- received capital support within the scope of TUBITAK 1512 Entrepreneurship Multi-Phase (Individual Young Enterprise) Program
- 2014-2017
- “Analyzing hRgr Gene Expression Levels in Subtypes of T cell Malignancies in Leukemic Patients“
- Burak Islek, Zeynep Karakas, Teoman Soysal, Rafi Suzme, Ugur Ozbek, Burcak Vural
- funded by TUBITAK Repatriation Research Scholarship Program (2232)-Master Thesis
- 2014-2015
- “Whole-Genome Analysis with high-risk acute leukemia patients“
- Yucel Erbilgin, Burak Islek
- funded by TUBITAK 1002 Short Term R&D Funding Program
EXPERIENCES
- 2016-ongoing
- Project & company direction
- GENESIST R&D / ITU ARI TECHNOPARK
- 2017-2018
- ISTANBUL TECHNICAL UNIVERSITY
- Institute of Informatics / High Performance Computing Laboratory
- Research Areas: Computer-aided drug design, Biomolecule modelling and Simulation, Protein-ligand interactions
- 2013-2017
- ISTANBUL UNIVERSITY
- Research Institute for Experimental Medicine (DETAE) / Hematology Lab.
- Research Areas: Affymetrix Genechip Array (microarray gene expression analysis via R) , Sanger sequencing and Next Generation sequencing in pediatric patients with leukemia & lymphoma, pathophysiology of genetics & blood disorders, molecular dynamics & and gene interactions in cancer pathways
- 2009 – 2011
- KOC UNIVERSITY
- Department of Chemical & Biological Engineering / Computational and Quantitative Biology Lab.
- Research areas: Drug designing, docking strategies, protein-protein & protein-ligand interactions